Inozyme Pharma shares owned by Summit Investment Advisors
Quarter-by-quarter ownership of Inozyme Pharma (INZY) shares owned by Summit Investment Advisors
from 13F filings
Historical chart of Summit Investment Advisors investment in Inozyme Pharma
Tip: Access up to 7 years of quarterly data
All positions including Inozyme Pharma held by Summit Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Inozyme Pharma by Summit Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $21k | 4.8k | 4.26 |
| 2023-09-30 | $12k | 2.8k | 4.20 |
| 2023-06-30 | $16k | 2.8k | 5.57 |
| 2022-03-31 | $3.0k | 692 | 4.34 |
| 2021-12-31 | $5.0k | 692 | 7.23 |
| 2021-09-30 | $8.0k | 692 | 11.56 |
| 2021-06-30 | $12k | 692 | 17.34 |
| 2021-03-31 | $14k | 692 | 20.23 |
| 2020-12-31 | $14k | 692 | 20.23 |
| 2020-09-30 | $18k | 692 | 26.01 |
More positions owned by Summit Investment Advisors
View all positions for Summit Investment Advisors